ADC Therapeutics: Q4 Earnings Insights
ADC Therapeutics Ltd
ADC Therapeutics Ltd ADCT | 0.00 |
ADC Therapeutics (NYSE:ADCT) just disclosed its Q4 earnings on Tuesday, March 10, 2026 at 07:30 AM.
Here's a brief overview of the earnings report.
Earnings
ADC Therapeutics beat estimated earnings by 68.97%, reporting an EPS of $-0.09 versus an estimate of $-0.29.
Revenue was up $6.15 million from the same period last year.
Earnings History Overview
The company beat on EPS by $0.19 in the last quarter, resulting in a 5.7% drop share price change the following day.
Here's a look at ADC Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -0.36 | -0.38 | -0.35 |
| EPS Actual | -0.19 | -0.25 | -0.22 | -0.25 |
| Revenue Estimate | 16.52M | 18.21M | 18.15M | 19.67M |
| Revenue Actual | 16.43M | 18.84M | 23.03M | 16.91M |
To track all earnings releases for ADC Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.